nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—ABCB1—Progesterone—uterine cancer	0.0337	0.393	CbGbCtD
Lamotrigine—ABCB1—Dactinomycin—uterine cancer	0.0267	0.311	CbGbCtD
Lamotrigine—ABCB1—Etoposide—uterine cancer	0.0151	0.176	CbGbCtD
Lamotrigine—ABCB1—Doxorubicin—uterine cancer	0.0103	0.12	CbGbCtD
Lamotrigine—UGT1A3—Metapathway biotransformation—AKR1B10—uterine cancer	0.000785	0.0142	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—PLXNA3—uterine cancer	0.00076	0.0137	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—AKR1B1—uterine cancer	0.00073	0.0132	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—PLXNA3—uterine cancer	0.000727	0.0131	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—PLXNA3—uterine cancer	0.000699	0.0126	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—PLXNA3—uterine cancer	0.000699	0.0126	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—NFE2L2—uterine cancer	0.000686	0.0124	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—PLXNA3—uterine cancer	0.000674	0.0121	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PLXNA3—uterine cancer	0.000674	0.0121	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—PLXNA3—uterine cancer	0.000664	0.012	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—GPX3—uterine cancer	0.000654	0.0118	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000644	0.0116	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—NFE2L2—uterine cancer	0.00057	0.0103	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—GPX3—uterine cancer	0.000566	0.0102	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—GPX3—uterine cancer	0.000544	0.0098	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—AKR1C1—uterine cancer	0.000536	0.00966	CbGpPWpGaD
Lamotrigine—UGT1A4—Biological oxidations—CYP11A1—uterine cancer	0.000533	0.0096	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000525	0.00947	CbGpPWpGaD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000511	0.00921	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000496	0.00894	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—HNF1B—uterine cancer	0.000494	0.0089	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—PLXNA3—uterine cancer	0.000474	0.00854	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—GPX3—uterine cancer	0.00047	0.00848	CbGpPWpGaD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000449	0.00809	CbGpPWpGaD
Lamotrigine—UGT1A3—Biological oxidations—CYP11A1—uterine cancer	0.000443	0.00798	CbGpPWpGaD
Lamotrigine—Hyperhidrosis—Etoposide—uterine cancer	0.00044	0.000513	CcSEcCtD
Lamotrigine—Pancreatitis—Epirubicin—uterine cancer	0.00044	0.000513	CcSEcCtD
Lamotrigine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000439	0.000511	CcSEcCtD
Lamotrigine—Angina pectoris—Epirubicin—uterine cancer	0.000437	0.000509	CcSEcCtD
Lamotrigine—UGT1A3—Metapathway biotransformation—CYP11A1—uterine cancer	0.000437	0.00787	CbGpPWpGaD
Lamotrigine—Anorexia—Etoposide—uterine cancer	0.000434	0.000506	CcSEcCtD
Lamotrigine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000433	0.000504	CcSEcCtD
Lamotrigine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000433	0.000504	CcSEcCtD
Lamotrigine—Bronchitis—Epirubicin—uterine cancer	0.000432	0.000503	CcSEcCtD
Lamotrigine—Diarrhoea—Dactinomycin—uterine cancer	0.000431	0.000502	CcSEcCtD
Lamotrigine—Pancytopenia—Epirubicin—uterine cancer	0.000427	0.000497	CcSEcCtD
Lamotrigine—Gastritis—Doxorubicin—uterine cancer	0.000426	0.000496	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000425	0.00766	CbGpPWpGaD
Lamotrigine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000424	0.000494	CcSEcCtD
Lamotrigine—Muscular weakness—Doxorubicin—uterine cancer	0.000424	0.000494	CcSEcCtD
Lamotrigine—Neutropenia—Epirubicin—uterine cancer	0.00042	0.000489	CcSEcCtD
Lamotrigine—Dysuria—Epirubicin—uterine cancer	0.00042	0.000489	CcSEcCtD
Lamotrigine—Abdominal distension—Doxorubicin—uterine cancer	0.000418	0.000487	CcSEcCtD
Lamotrigine—Asthma—Doxorubicin—uterine cancer	0.000416	0.000484	CcSEcCtD
Lamotrigine—Influenza—Doxorubicin—uterine cancer	0.000416	0.000484	CcSEcCtD
Lamotrigine—Dysphagia—Doxorubicin—uterine cancer	0.000416	0.000484	CcSEcCtD
Lamotrigine—Pollakiuria—Epirubicin—uterine cancer	0.000415	0.000483	CcSEcCtD
Lamotrigine—UGT1A3—Metapathway biotransformation—AKR1C3—uterine cancer	0.000412	0.00743	CbGpPWpGaD
Lamotrigine—Eosinophilia—Doxorubicin—uterine cancer	0.000411	0.000479	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00041	0.000477	CcSEcCtD
Lamotrigine—Paraesthesia—Etoposide—uterine cancer	0.000409	0.000476	CcSEcCtD
Lamotrigine—Weight increased—Epirubicin—uterine cancer	0.000409	0.000476	CcSEcCtD
Lamotrigine—Pancreatitis—Doxorubicin—uterine cancer	0.000407	0.000474	CcSEcCtD
Lamotrigine—Weight decreased—Epirubicin—uterine cancer	0.000406	0.000473	CcSEcCtD
Lamotrigine—Dyspnoea—Etoposide—uterine cancer	0.000406	0.000473	CcSEcCtD
Lamotrigine—Hyperglycaemia—Epirubicin—uterine cancer	0.000405	0.000472	CcSEcCtD
Lamotrigine—Somnolence—Etoposide—uterine cancer	0.000405	0.000472	CcSEcCtD
Lamotrigine—Angina pectoris—Doxorubicin—uterine cancer	0.000405	0.000471	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000403	0.00727	CbGpPWpGaD
Lamotrigine—Pneumonia—Epirubicin—uterine cancer	0.000403	0.000469	CcSEcCtD
Lamotrigine—Infestation—Epirubicin—uterine cancer	0.0004	0.000466	CcSEcCtD
Lamotrigine—Infestation NOS—Epirubicin—uterine cancer	0.0004	0.000466	CcSEcCtD
Lamotrigine—Drowsiness—Epirubicin—uterine cancer	0.0004	0.000466	CcSEcCtD
Lamotrigine—Vomiting—Dactinomycin—uterine cancer	0.0004	0.000466	CcSEcCtD
Lamotrigine—Bronchitis—Doxorubicin—uterine cancer	0.0004	0.000465	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—HNF1B—uterine cancer	0.000399	0.0072	CbGpPWpGaD
Lamotrigine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000397	0.000462	CcSEcCtD
Lamotrigine—Rash—Dactinomycin—uterine cancer	0.000397	0.000462	CcSEcCtD
Lamotrigine—Decreased appetite—Etoposide—uterine cancer	0.000396	0.000461	CcSEcCtD
Lamotrigine—Pancytopenia—Doxorubicin—uterine cancer	0.000395	0.00046	CcSEcCtD
Lamotrigine—Renal failure—Epirubicin—uterine cancer	0.000394	0.000458	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000393	0.000458	CcSEcCtD
Lamotrigine—Fatigue—Etoposide—uterine cancer	0.000393	0.000457	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000393	0.000457	CcSEcCtD
Lamotrigine—UGT1A4—Biological oxidations—CYP19A1—uterine cancer	0.000392	0.00706	CbGpPWpGaD
Lamotrigine—Stomatitis—Epirubicin—uterine cancer	0.00039	0.000455	CcSEcCtD
Lamotrigine—Pain—Etoposide—uterine cancer	0.00039	0.000454	CcSEcCtD
Lamotrigine—Constipation—Etoposide—uterine cancer	0.00039	0.000454	CcSEcCtD
Lamotrigine—Urinary tract infection—Epirubicin—uterine cancer	0.000389	0.000453	CcSEcCtD
Lamotrigine—Conjunctivitis—Epirubicin—uterine cancer	0.000389	0.000453	CcSEcCtD
Lamotrigine—Dysuria—Doxorubicin—uterine cancer	0.000389	0.000453	CcSEcCtD
Lamotrigine—Neutropenia—Doxorubicin—uterine cancer	0.000389	0.000453	CcSEcCtD
Lamotrigine—UGT1A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000386	0.00697	CbGpPWpGaD
Lamotrigine—Sweating—Epirubicin—uterine cancer	0.000384	0.000447	CcSEcCtD
Lamotrigine—Pollakiuria—Doxorubicin—uterine cancer	0.000384	0.000447	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—HNF1B—uterine cancer	0.000382	0.00689	CbGpPWpGaD
Lamotrigine—Haematuria—Epirubicin—uterine cancer	0.000382	0.000445	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000379	0.000442	CcSEcCtD
Lamotrigine—Weight increased—Doxorubicin—uterine cancer	0.000378	0.00044	CcSEcCtD
Lamotrigine—Epistaxis—Epirubicin—uterine cancer	0.000378	0.00044	CcSEcCtD
Lamotrigine—Weight decreased—Doxorubicin—uterine cancer	0.000376	0.000438	CcSEcCtD
Lamotrigine—Sinusitis—Epirubicin—uterine cancer	0.000376	0.000438	CcSEcCtD
Lamotrigine—Feeling abnormal—Etoposide—uterine cancer	0.000375	0.000437	CcSEcCtD
Lamotrigine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000375	0.000437	CcSEcCtD
Lamotrigine—Nausea—Dactinomycin—uterine cancer	0.000374	0.000435	CcSEcCtD
Lamotrigine—Agranulocytosis—Epirubicin—uterine cancer	0.000374	0.000435	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000373	0.00672	CbGpPWpGaD
Lamotrigine—Pneumonia—Doxorubicin—uterine cancer	0.000373	0.000434	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Etoposide—uterine cancer	0.000373	0.000434	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000372	0.00671	CbGpPWpGaD
Lamotrigine—Drowsiness—Doxorubicin—uterine cancer	0.000371	0.000431	CcSEcCtD
Lamotrigine—Infestation NOS—Doxorubicin—uterine cancer	0.000371	0.000431	CcSEcCtD
Lamotrigine—Infestation—Doxorubicin—uterine cancer	0.000371	0.000431	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000367	0.000428	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—HNF1B—uterine cancer	0.000367	0.00662	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HNF1B—uterine cancer	0.000367	0.00662	CbGpPWpGaD
Lamotrigine—Renal failure—Doxorubicin—uterine cancer	0.000364	0.000424	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000363	0.000423	CcSEcCtD
Lamotrigine—Urticaria—Etoposide—uterine cancer	0.000362	0.000422	CcSEcCtD
Lamotrigine—Haemoglobin—Epirubicin—uterine cancer	0.000361	0.000421	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—uterine cancer	0.000361	0.000421	CcSEcCtD
Lamotrigine—Rhinitis—Epirubicin—uterine cancer	0.00036	0.00042	CcSEcCtD
Lamotrigine—Body temperature increased—Etoposide—uterine cancer	0.00036	0.000419	CcSEcCtD
Lamotrigine—Abdominal pain—Etoposide—uterine cancer	0.00036	0.000419	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—uterine cancer	0.00036	0.000419	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—uterine cancer	0.00036	0.000419	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—uterine cancer	0.000359	0.000419	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—uterine cancer	0.000359	0.000419	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—uterine cancer	0.000358	0.000417	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—uterine cancer	0.000357	0.000415	CcSEcCtD
Lamotrigine—Sweating—Doxorubicin—uterine cancer	0.000355	0.000414	CcSEcCtD
Lamotrigine—Oedema peripheral—Epirubicin—uterine cancer	0.000354	0.000412	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—HNF1B—uterine cancer	0.000354	0.00638	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HNF1B—uterine cancer	0.000354	0.00638	CbGpPWpGaD
Lamotrigine—Haematuria—Doxorubicin—uterine cancer	0.000353	0.000411	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—uterine cancer	0.000353	0.000411	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—uterine cancer	0.000349	0.000407	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—uterine cancer	0.000348	0.000405	CcSEcCtD
Lamotrigine—Agranulocytosis—Doxorubicin—uterine cancer	0.000346	0.000403	CcSEcCtD
Lamotrigine—Erythema multiforme—Epirubicin—uterine cancer	0.00034	0.000396	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—uterine cancer	0.000336	0.000391	CcSEcCtD
Lamotrigine—Hypersensitivity—Etoposide—uterine cancer	0.000336	0.000391	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—uterine cancer	0.000335	0.00039	CcSEcCtD
Lamotrigine—Haemoglobin—Doxorubicin—uterine cancer	0.000334	0.000389	CcSEcCtD
Lamotrigine—Flushing—Epirubicin—uterine cancer	0.000334	0.000389	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—uterine cancer	0.000333	0.000388	CcSEcCtD
Lamotrigine—Haemorrhage—Doxorubicin—uterine cancer	0.000333	0.000387	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—uterine cancer	0.000333	0.000387	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000331	0.000385	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—uterine cancer	0.00033	0.000384	CcSEcCtD
Lamotrigine—Oedema peripheral—Doxorubicin—uterine cancer	0.000328	0.000382	CcSEcCtD
Lamotrigine—Asthenia—Etoposide—uterine cancer	0.000327	0.000381	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000327	0.000381	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—uterine cancer	0.000326	0.00038	CcSEcCtD
Lamotrigine—UGT1A3—Biological oxidations—CYP19A1—uterine cancer	0.000326	0.00587	CbGpPWpGaD
Lamotrigine—Mediastinal disorder—Epirubicin—uterine cancer	0.000324	0.000377	CcSEcCtD
Lamotrigine—Chills—Epirubicin—uterine cancer	0.000323	0.000376	CcSEcCtD
Lamotrigine—Pruritus—Etoposide—uterine cancer	0.000322	0.000375	CcSEcCtD
Lamotrigine—UGT1A3—Metapathway biotransformation—CYP19A1—uterine cancer	0.000321	0.00579	CbGpPWpGaD
Lamotrigine—Alopecia—Epirubicin—uterine cancer	0.000318	0.00037	CcSEcCtD
Lamotrigine—Mental disorder—Epirubicin—uterine cancer	0.000315	0.000367	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000315	0.00567	CbGpPWpGaD
Lamotrigine—Erythema multiforme—Doxorubicin—uterine cancer	0.000314	0.000366	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—uterine cancer	0.000313	0.000364	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—uterine cancer	0.000313	0.000364	CcSEcCtD
Lamotrigine—Diarrhoea—Etoposide—uterine cancer	0.000312	0.000363	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—uterine cancer	0.000311	0.000362	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—uterine cancer	0.00031	0.000361	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—uterine cancer	0.000309	0.000359	CcSEcCtD
Lamotrigine—Flatulence—Epirubicin—uterine cancer	0.000308	0.000359	CcSEcCtD
Lamotrigine—Tension—Epirubicin—uterine cancer	0.000307	0.000358	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—uterine cancer	0.000306	0.000357	CcSEcCtD
Lamotrigine—Nervousness—Epirubicin—uterine cancer	0.000304	0.000354	CcSEcCtD
Lamotrigine—Back pain—Epirubicin—uterine cancer	0.000303	0.000353	CcSEcCtD
Lamotrigine—Angiopathy—Doxorubicin—uterine cancer	0.000302	0.000351	CcSEcCtD
Lamotrigine—Dizziness—Etoposide—uterine cancer	0.000301	0.000351	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—uterine cancer	0.000301	0.00035	CcSEcCtD
Lamotrigine—Mediastinal disorder—Doxorubicin—uterine cancer	0.0003	0.000349	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—uterine cancer	0.000298	0.000348	CcSEcCtD
Lamotrigine—Vision blurred—Epirubicin—uterine cancer	0.000295	0.000343	CcSEcCtD
Lamotrigine—Alopecia—Doxorubicin—uterine cancer	0.000294	0.000342	CcSEcCtD
Lamotrigine—Mental disorder—Doxorubicin—uterine cancer	0.000291	0.000339	CcSEcCtD
Lamotrigine—Ill-defined disorder—Epirubicin—uterine cancer	0.00029	0.000338	CcSEcCtD
Lamotrigine—Vomiting—Etoposide—uterine cancer	0.00029	0.000337	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—uterine cancer	0.00029	0.000337	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—uterine cancer	0.00029	0.000337	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—uterine cancer	0.000289	0.000337	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—uterine cancer	0.000288	0.000335	CcSEcCtD
Lamotrigine—Rash—Etoposide—uterine cancer	0.000287	0.000335	CcSEcCtD
Lamotrigine—Dermatitis—Etoposide—uterine cancer	0.000287	0.000334	CcSEcCtD
Lamotrigine—Headache—Etoposide—uterine cancer	0.000285	0.000332	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—uterine cancer	0.000285	0.000332	CcSEcCtD
Lamotrigine—Tension—Doxorubicin—uterine cancer	0.000284	0.000331	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—uterine cancer	0.000284	0.00033	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—uterine cancer	0.000282	0.000329	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—uterine cancer	0.000281	0.000328	CcSEcCtD
Lamotrigine—Vertigo—Epirubicin—uterine cancer	0.000281	0.000327	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—uterine cancer	0.000281	0.000327	CcSEcCtD
Lamotrigine—Leukopenia—Epirubicin—uterine cancer	0.00028	0.000326	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—uterine cancer	0.00028	0.000326	CcSEcCtD
Lamotrigine—Muscle spasms—Doxorubicin—uterine cancer	0.000278	0.000324	CcSEcCtD
Lamotrigine—Palpitations—Epirubicin—uterine cancer	0.000277	0.000322	CcSEcCtD
Lamotrigine—Loss of consciousness—Epirubicin—uterine cancer	0.000275	0.00032	CcSEcCtD
Lamotrigine—Cough—Epirubicin—uterine cancer	0.000273	0.000318	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—uterine cancer	0.000273	0.000318	CcSEcCtD
Lamotrigine—Convulsion—Epirubicin—uterine cancer	0.000271	0.000316	CcSEcCtD
Lamotrigine—Nausea—Etoposide—uterine cancer	0.000271	0.000315	CcSEcCtD
Lamotrigine—Hypertension—Epirubicin—uterine cancer	0.00027	0.000315	CcSEcCtD
Lamotrigine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000269	0.000313	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—uterine cancer	0.000268	0.000312	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—uterine cancer	0.000266	0.00031	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—uterine cancer	0.000266	0.00031	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—uterine cancer	0.000266	0.00031	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—uterine cancer	0.000266	0.00031	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—uterine cancer	0.000265	0.000309	CcSEcCtD
Lamotrigine—Discomfort—Epirubicin—uterine cancer	0.000263	0.000307	CcSEcCtD
Lamotrigine—Malaise—Doxorubicin—uterine cancer	0.000261	0.000304	CcSEcCtD
Lamotrigine—Dry mouth—Epirubicin—uterine cancer	0.000261	0.000303	CcSEcCtD
Lamotrigine—Vertigo—Doxorubicin—uterine cancer	0.00026	0.000303	CcSEcCtD
Lamotrigine—Syncope—Doxorubicin—uterine cancer	0.00026	0.000302	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—uterine cancer	0.000259	0.000302	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—uterine cancer	0.000258	0.0003	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—uterine cancer	0.000256	0.000298	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—uterine cancer	0.000255	0.000297	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—uterine cancer	0.000254	0.000296	CcSEcCtD
Lamotrigine—Infection—Epirubicin—uterine cancer	0.000254	0.000295	CcSEcCtD
Lamotrigine—Cough—Doxorubicin—uterine cancer	0.000253	0.000294	CcSEcCtD
Lamotrigine—Shock—Epirubicin—uterine cancer	0.000251	0.000293	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—uterine cancer	0.000251	0.000292	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—MET—uterine cancer	0.000251	0.00452	CbGpPWpGaD
Lamotrigine—Nervous system disorder—Epirubicin—uterine cancer	0.00025	0.000292	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—uterine cancer	0.00025	0.000291	CcSEcCtD
Lamotrigine—Hypertension—Doxorubicin—uterine cancer	0.00025	0.000291	CcSEcCtD
Lamotrigine—Tachycardia—Epirubicin—uterine cancer	0.000249	0.00029	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—HNF1B—uterine cancer	0.000249	0.00448	CbGpPWpGaD
Lamotrigine—Hyperhidrosis—Epirubicin—uterine cancer	0.000247	0.000288	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—uterine cancer	0.000247	0.000287	CcSEcCtD
Lamotrigine—Chest pain—Doxorubicin—uterine cancer	0.000247	0.000287	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—uterine cancer	0.000247	0.000287	CcSEcCtD
Lamotrigine—Anxiety—Doxorubicin—uterine cancer	0.000246	0.000286	CcSEcCtD
Lamotrigine—Discomfort—Doxorubicin—uterine cancer	0.000244	0.000284	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—uterine cancer	0.000243	0.000284	CcSEcCtD
Lamotrigine—Dry mouth—Doxorubicin—uterine cancer	0.000241	0.000281	CcSEcCtD
Lamotrigine—Confusional state—Doxorubicin—uterine cancer	0.000238	0.000277	CcSEcCtD
Lamotrigine—Oedema—Doxorubicin—uterine cancer	0.000236	0.000275	CcSEcCtD
Lamotrigine—Infection—Doxorubicin—uterine cancer	0.000235	0.000273	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000233	0.000271	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—uterine cancer	0.000232	0.000271	CcSEcCtD
Lamotrigine—Nervous system disorder—Doxorubicin—uterine cancer	0.000232	0.00027	CcSEcCtD
Lamotrigine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000231	0.000269	CcSEcCtD
Lamotrigine—Insomnia—Epirubicin—uterine cancer	0.000231	0.000269	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—uterine cancer	0.000231	0.000269	CcSEcCtD
Lamotrigine—Paraesthesia—Epirubicin—uterine cancer	0.000229	0.000267	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000228	0.000266	CcSEcCtD
Lamotrigine—Dyspnoea—Epirubicin—uterine cancer	0.000228	0.000265	CcSEcCtD
Lamotrigine—Somnolence—Epirubicin—uterine cancer	0.000227	0.000264	CcSEcCtD
Lamotrigine—Anorexia—Doxorubicin—uterine cancer	0.000225	0.000262	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—uterine cancer	0.000225	0.000262	CcSEcCtD
Lamotrigine—Decreased appetite—Epirubicin—uterine cancer	0.000222	0.000259	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00022	0.000257	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—uterine cancer	0.00022	0.000256	CcSEcCtD
Lamotrigine—Pain—Epirubicin—uterine cancer	0.000218	0.000254	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—uterine cancer	0.000218	0.000254	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—SMAD3—uterine cancer	0.000218	0.00393	CbGpPWpGaD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000215	0.000251	CcSEcCtD
Lamotrigine—Insomnia—Doxorubicin—uterine cancer	0.000214	0.000249	CcSEcCtD
Lamotrigine—Paraesthesia—Doxorubicin—uterine cancer	0.000212	0.000247	CcSEcCtD
Lamotrigine—Dyspnoea—Doxorubicin—uterine cancer	0.000211	0.000245	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—NDUFB11—uterine cancer	0.000211	0.0038	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—SRD5A2—uterine cancer	0.000211	0.0038	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Epirubicin—uterine cancer	0.00021	0.000245	CcSEcCtD
Lamotrigine—Somnolence—Doxorubicin—uterine cancer	0.00021	0.000245	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000209	0.000243	CcSEcCtD
Lamotrigine—Dyspepsia—Doxorubicin—uterine cancer	0.000208	0.000242	CcSEcCtD
Lamotrigine—Decreased appetite—Doxorubicin—uterine cancer	0.000205	0.000239	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000204	0.000238	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—uterine cancer	0.000204	0.000237	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—uterine cancer	0.000203	0.000236	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—MET—uterine cancer	0.000203	0.00365	CbGpPWpGaD
Lamotrigine—Pain—Doxorubicin—uterine cancer	0.000202	0.000235	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—uterine cancer	0.000202	0.000235	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—uterine cancer	0.000202	0.000235	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—uterine cancer	0.000202	0.000235	CcSEcCtD
Lamotrigine—Feeling abnormal—Doxorubicin—uterine cancer	0.000195	0.000227	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—MET—uterine cancer	0.000194	0.00349	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000193	0.000225	CcSEcCtD
Lamotrigine—Hypersensitivity—Epirubicin—uterine cancer	0.000188	0.000219	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—uterine cancer	0.000188	0.000219	CcSEcCtD
Lamotrigine—Abdominal pain—Doxorubicin—uterine cancer	0.000187	0.000218	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—uterine cancer	0.000187	0.000218	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—MET—uterine cancer	0.000186	0.00336	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MET—uterine cancer	0.000186	0.00336	CbGpPWpGaD
Lamotrigine—Asthenia—Epirubicin—uterine cancer	0.000183	0.000213	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—ERBB2—uterine cancer	0.000183	0.0033	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000182	0.00328	CbGpPWpGaD
Lamotrigine—Pruritus—Epirubicin—uterine cancer	0.000181	0.00021	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—MET—uterine cancer	0.00018	0.00324	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MET—uterine cancer	0.00018	0.00324	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MET—uterine cancer	0.000179	0.00322	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—SMAD3—uterine cancer	0.000176	0.00318	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000176	0.00317	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NDUFB11—uterine cancer	0.000175	0.00316	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—SRD5A2—uterine cancer	0.000175	0.00316	CbGpPWpGaD
Lamotrigine—Diarrhoea—Epirubicin—uterine cancer	0.000175	0.000204	CcSEcCtD
Lamotrigine—Hypersensitivity—Doxorubicin—uterine cancer	0.000174	0.000203	CcSEcCtD
Lamotrigine—Asthenia—Doxorubicin—uterine cancer	0.00017	0.000197	CcSEcCtD
Lamotrigine—Dizziness—Epirubicin—uterine cancer	0.000169	0.000197	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—SMAD3—uterine cancer	0.000169	0.00304	CbGpPWpGaD
Lamotrigine—Pruritus—Doxorubicin—uterine cancer	0.000167	0.000195	CcSEcCtD
Lamotrigine—Vomiting—Epirubicin—uterine cancer	0.000162	0.000189	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—SMAD3—uterine cancer	0.000162	0.00292	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—SMAD3—uterine cancer	0.000162	0.00292	CbGpPWpGaD
Lamotrigine—Diarrhoea—Doxorubicin—uterine cancer	0.000162	0.000188	CcSEcCtD
Lamotrigine—Rash—Epirubicin—uterine cancer	0.000161	0.000188	CcSEcCtD
Lamotrigine—Dermatitis—Epirubicin—uterine cancer	0.000161	0.000187	CcSEcCtD
Lamotrigine—Headache—Epirubicin—uterine cancer	0.00016	0.000186	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000157	0.00283	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—SMAD3—uterine cancer	0.000156	0.00282	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—SMAD3—uterine cancer	0.000156	0.00282	CbGpPWpGaD
Lamotrigine—Dizziness—Doxorubicin—uterine cancer	0.000156	0.000182	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—AKR1B1—uterine cancer	0.000152	0.00274	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—STAR—uterine cancer	0.000152	0.00274	CbGpPWpGaD
Lamotrigine—Nausea—Epirubicin—uterine cancer	0.000152	0.000177	CcSEcCtD
Lamotrigine—Vomiting—Doxorubicin—uterine cancer	0.00015	0.000175	CcSEcCtD
Lamotrigine—Rash—Doxorubicin—uterine cancer	0.000149	0.000174	CcSEcCtD
Lamotrigine—Dermatitis—Doxorubicin—uterine cancer	0.000149	0.000173	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—ERBB2—uterine cancer	0.000148	0.00267	CbGpPWpGaD
Lamotrigine—Headache—Doxorubicin—uterine cancer	0.000148	0.000172	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000145	0.00261	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MET—uterine cancer	0.000145	0.00261	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—ERBB2—uterine cancer	0.000142	0.00255	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—VEGFA—uterine cancer	0.000141	0.00254	CbGpPWpGaD
Lamotrigine—Nausea—Doxorubicin—uterine cancer	0.00014	0.000163	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—NRAS—uterine cancer	0.000139	0.00251	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MET—uterine cancer	0.000138	0.00249	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—ERBB2—uterine cancer	0.000136	0.00245	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—ERBB2—uterine cancer	0.000136	0.00245	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000135	0.00243	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MET—uterine cancer	0.000133	0.0024	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MET—uterine cancer	0.000133	0.0024	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—ERBB2—uterine cancer	0.000131	0.00237	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—ERBB2—uterine cancer	0.000131	0.00237	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—ERBB2—uterine cancer	0.000131	0.00236	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MET—uterine cancer	0.000128	0.00231	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MET—uterine cancer	0.000128	0.00231	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000128	0.00231	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000128	0.0023	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—STAR—uterine cancer	0.000127	0.00228	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKR1B1—uterine cancer	0.000127	0.00228	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MET—uterine cancer	0.000126	0.00228	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—KRAS—uterine cancer	0.00012	0.00216	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—POLD1—uterine cancer	0.000119	0.00215	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CTNNB1—uterine cancer	0.000114	0.00206	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—VEGFA—uterine cancer	0.000114	0.00206	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000113	0.00203	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—NRAS—uterine cancer	0.000113	0.00203	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKR1C1—uterine cancer	0.000112	0.00201	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—SMAD3—uterine cancer	0.00011	0.00198	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—VEGFA—uterine cancer	0.000109	0.00197	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—NRAS—uterine cancer	0.000108	0.00194	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EP300—uterine cancer	0.000106	0.00192	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—ERBB2—uterine cancer	0.000106	0.00191	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—VEGFA—uterine cancer	0.000105	0.00189	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—VEGFA—uterine cancer	0.000105	0.00189	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000105	0.00188	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—NRAS—uterine cancer	0.000104	0.00187	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—NRAS—uterine cancer	0.000104	0.00187	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—HRAS—uterine cancer	0.000102	0.00184	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—ERBB2—uterine cancer	0.000101	0.00182	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—VEGFA—uterine cancer	0.000101	0.00182	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—VEGFA—uterine cancer	0.000101	0.00182	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—VEGFA—uterine cancer	0.000101	0.00181	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—NRAS—uterine cancer	9.99e-05	0.0018	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—NRAS—uterine cancer	9.99e-05	0.0018	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—RRM2—uterine cancer	9.96e-05	0.0018	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—NRAS—uterine cancer	9.94e-05	0.00179	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—POLD1—uterine cancer	9.93e-05	0.00179	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ERBB2—uterine cancer	9.71e-05	0.00175	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—ERBB2—uterine cancer	9.71e-05	0.00175	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—KRAS—uterine cancer	9.7e-05	0.00175	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—DCN—uterine cancer	9.67e-05	0.00174	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	9.49e-05	0.00171	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—ERBB2—uterine cancer	9.37e-05	0.00169	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—ERBB2—uterine cancer	9.37e-05	0.00169	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKR1C1—uterine cancer	9.29e-05	0.00167	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—KRAS—uterine cancer	9.28e-05	0.00167	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—CTNNB1—uterine cancer	9.25e-05	0.00167	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—ERBB2—uterine cancer	9.23e-05	0.00166	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CYP11A1—uterine cancer	9.11e-05	0.00164	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MET—uterine cancer	9.01e-05	0.00162	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	8.94e-05	0.00161	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—KRAS—uterine cancer	8.91e-05	0.00161	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—KRAS—uterine cancer	8.91e-05	0.00161	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	8.86e-05	0.0016	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CTNNB1—uterine cancer	8.85e-05	0.00159	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKR1C3—uterine cancer	8.6e-05	0.00155	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EP300—uterine cancer	8.6e-05	0.00155	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—KRAS—uterine cancer	8.6e-05	0.00155	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—KRAS—uterine cancer	8.6e-05	0.00155	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.56e-05	0.00154	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—KRAS—uterine cancer	8.56e-05	0.00154	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	8.51e-05	0.00153	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CTNNB1—uterine cancer	8.5e-05	0.00153	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CTNNB1—uterine cancer	8.5e-05	0.00153	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	8.39e-05	0.00151	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—RRM2—uterine cancer	8.28e-05	0.00149	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—HRAS—uterine cancer	8.24e-05	0.00149	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EP300—uterine cancer	8.22e-05	0.00148	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CTNNB1—uterine cancer	8.2e-05	0.00148	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CTNNB1—uterine cancer	8.2e-05	0.00148	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—VEGFA—uterine cancer	8.14e-05	0.00147	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—NRAS—uterine cancer	8.04e-05	0.00145	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—DCN—uterine cancer	8.04e-05	0.00145	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EP300—uterine cancer	7.9e-05	0.00142	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EP300—uterine cancer	7.9e-05	0.00142	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—HRAS—uterine cancer	7.89e-05	0.00142	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—VEGFA—uterine cancer	7.79e-05	0.0014	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—NRAS—uterine cancer	7.69e-05	0.00139	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EP300—uterine cancer	7.62e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EP300—uterine cancer	7.62e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—uterine cancer	7.58e-05	0.00137	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—HRAS—uterine cancer	7.58e-05	0.00137	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CYP11A1—uterine cancer	7.57e-05	0.00136	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—VEGFA—uterine cancer	7.48e-05	0.00135	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—VEGFA—uterine cancer	7.48e-05	0.00135	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—NRAS—uterine cancer	7.39e-05	0.00133	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—NRAS—uterine cancer	7.39e-05	0.00133	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—uterine cancer	7.31e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—uterine cancer	7.31e-05	0.00132	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—HRAS—uterine cancer	7.27e-05	0.00131	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	7.26e-05	0.00131	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—VEGFA—uterine cancer	7.21e-05	0.0013	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—VEGFA—uterine cancer	7.21e-05	0.0013	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKR1C3—uterine cancer	7.15e-05	0.00129	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—NRAS—uterine cancer	7.13e-05	0.00128	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—NRAS—uterine cancer	7.13e-05	0.00128	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—VEGFA—uterine cancer	7.11e-05	0.00128	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—NRAS—uterine cancer	7.02e-05	0.00127	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—KRAS—uterine cancer	6.92e-05	0.00125	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CYP19A1—uterine cancer	6.7e-05	0.00121	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—STK11—uterine cancer	6.7e-05	0.00121	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—KRAS—uterine cancer	6.62e-05	0.00119	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—ERBB2—uterine cancer	6.59e-05	0.00119	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—AKT1—uterine cancer	6.42e-05	0.00116	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—KRAS—uterine cancer	6.36e-05	0.00115	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—KRAS—uterine cancer	6.36e-05	0.00115	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.34e-05	0.00114	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—KRAS—uterine cancer	6.13e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—KRAS—uterine cancer	6.13e-05	0.00111	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—KRAS—uterine cancer	6.04e-05	0.00109	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—HRAS—uterine cancer	5.88e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CTNNB1—uterine cancer	5.76e-05	0.00104	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—HRAS—uterine cancer	5.63e-05	0.00101	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—STK11—uterine cancer	5.57e-05	0.001	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CYP19A1—uterine cancer	5.57e-05	0.001	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SRD5A2—uterine cancer	5.55e-05	0.001	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NDUFB11—uterine cancer	5.55e-05	0.001	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—uterine cancer	5.41e-05	0.000975	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—uterine cancer	5.41e-05	0.000975	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EP300—uterine cancer	5.36e-05	0.000965	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.35e-05	0.000965	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—uterine cancer	5.21e-05	0.00094	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—HRAS—uterine cancer	5.21e-05	0.00094	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—AKT1—uterine cancer	5.19e-05	0.000937	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—uterine cancer	5.14e-05	0.000926	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—VEGFA—uterine cancer	5.07e-05	0.000914	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—MTHFR—uterine cancer	5.04e-05	0.000908	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—NRAS—uterine cancer	5.01e-05	0.000903	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—AKT1—uterine cancer	4.97e-05	0.000896	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—AKT1—uterine cancer	4.77e-05	0.000861	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—AKT1—uterine cancer	4.77e-05	0.000861	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.65e-05	0.000839	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—AKT1—uterine cancer	4.6e-05	0.00083	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—AKT1—uterine cancer	4.6e-05	0.00083	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—KRAS—uterine cancer	4.31e-05	0.000777	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.31e-05	0.000777	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—MTHFR—uterine cancer	4.19e-05	0.000755	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.07e-05	0.000734	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKR1B1—uterine cancer	4.01e-05	0.000723	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—STAR—uterine cancer	4.01e-05	0.000723	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.97e-05	0.000716	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.79e-05	0.000682	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—uterine cancer	3.67e-05	0.000661	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.58e-05	0.000646	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—AKT1—uterine cancer	3.24e-05	0.000583	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—POLD1—uterine cancer	3.15e-05	0.000567	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.05e-05	0.000549	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKR1C1—uterine cancer	2.94e-05	0.000531	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTEN—uterine cancer	2.8e-05	0.000505	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.8e-05	0.000505	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.71e-05	0.000488	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—EP300—uterine cancer	2.67e-05	0.000482	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—RRM2—uterine cancer	2.62e-05	0.000473	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—DCN—uterine cancer	2.55e-05	0.000459	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP11A1—uterine cancer	2.4e-05	0.000433	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTEN—uterine cancer	2.33e-05	0.00042	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.29e-05	0.000412	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKR1C3—uterine cancer	2.27e-05	0.000409	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—EP300—uterine cancer	2.22e-05	0.0004	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PIK3CA—uterine cancer	1.98e-05	0.000356	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—STK11—uterine cancer	1.77e-05	0.000318	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP19A1—uterine cancer	1.77e-05	0.000318	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PIK3CA—uterine cancer	1.64e-05	0.000296	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—AKT1—uterine cancer	1.61e-05	0.000291	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—AKT1—uterine cancer	1.34e-05	0.000242	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—MTHFR—uterine cancer	1.33e-05	0.000239	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTEN—uterine cancer	7.38e-06	0.000133	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—EP300—uterine cancer	7.04e-06	0.000127	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PIK3CA—uterine cancer	5.21e-06	9.39e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—AKT1—uterine cancer	4.25e-06	7.67e-05	CbGpPWpGaD
